Videoconference and publication of the results for the 2019-2020 financial year, on June 4, 2020 May 25, 2020 May 25, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis April 20, 2020 April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin April 6, 2020 April 6, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell January 28, 2020 January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020 January 13, 2020 January 13, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019) December 3, 2019 December 3, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association September 10, 2019 September 10, 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP September 4, 2019 September 4, 2019
MedinCell partners to address the untapped financial potential in Animal Health August 28, 2019 August 28, 2019
